CoChat

Δ9‐tetrahydrocannabinol (Δ9‐THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease

Open access
Carroll, C. B., Zeissler, M.‐L., Hanemann, C. O., Zajicek, J. P. · 2012 · Neuropathology and Applied Neurobiology
Cited by 104

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

C. B. Carroll, M.‐L. Zeissler, C. O. Hanemann and J. P. Zajicek (2012) Neuropathology and Applied Neurobiology38, 535–547 Δ 9‐tetrahydrocannabinol (Δ 9‐THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease Aims:Δ 9‐tetrahydrocannabinol (Δ 9‐THC) is neuroprotective in models of Parkinson's disease (PD). Although CB1 receptors are increased within the basal ganglia of PD patients and animal models, current evidence suggests a role for CB1 receptor‐independent mechanisms. Here, we utilized a human neuronal cell culture PD model to further investigate the protective properties of Δ 9‐THC. Methods: Differentiated SH‐SY5Y neuroblastoma cells were exposed to PD‐relevant toxins: 1‐methyl‐4‐phenylpyridinium (MPP+), lactacystin and paraquat. Changes in CB1 receptor level were determined by quantitative polymerase chain reaction and Western blotting. Cannabinoids and modulatory compounds were co‐administered with toxins for 48 h and the effects on cell death, viability, apoptosis and oxidative stress assessed. Results: We found CB1 receptor up‐regulation in response to MPP+, lactacystin and paraquat and a protective effect of Δ 9‐THC against all three toxins. This neuroprotective effect was not reproduced by the CB1 receptor agonist WIN55,212‐2 or blocked by the CB1 antagonist AM251. Furthermore, the antioxidants α‐tocopherol and butylhydroxytoluene as well as the antioxidant cannabinoids, nabilone and cannabidiol were unable to elicit the same neuroprotection as Δ 9‐THC. However, the peroxisome proliferator‐activated receptor‐gamma (PPARγ) antagonist T0070907 dose‐dependently blocked the neuroprotective, antioxidant and anti‐apoptotic effects of Δ 9‐THC, while the PPARγ agonist pioglitazone resulted in protection from MPP+‐induced neurotoxicity. Furthermore, Δ 9‐THC increased PPARγ expression in MPP+‐treated SH‐SY5Y cells, another indicator of PPARγ activation. Conclusions: We have demonstrated up‐regulation of the CB1 receptor in direct response to neuronal injury in a human PD cell culture model, and a direct neuronal protective effect of Δ 9‐THC that may be mediated through PPARγ activation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2990.2011.01248.x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 104

Metadata

Authors
Carroll, C. B., Zeissler, M. ‐., Hanemann, C. O., & Zajicek, J. P.
Venue
Neuropathology and Applied Neurobiology
Publisher
Wiley
Published
2012-09-17
Volume
38
Issue
6
Pages
535-547
ISSN
  • 0305-1846 (ISSN-L)
  • 1365-2990
OpenAlex
W2142612127
Cited by
104
References
8
FWCI
5.16
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.